Correlation Between Bionoid Pharma and Avicanna

Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Avicanna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Avicanna into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bionoid Pharma and Avicanna, you can compare the effects of market volatilities on Bionoid Pharma and Avicanna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Avicanna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Avicanna.

Diversification Opportunities for Bionoid Pharma and Avicanna

-0.52

Correlation Coefficient

Bionoid Pharma  Avicanna

Excellent diversification

The 3 months correlation between Bionoid and Avicanna is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Avicanna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avicanna and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Avicanna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avicanna has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Avicanna go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Avicanna

Given the investment horizon of 90 days Bionoid Pharma is expected to under-perform the Avicanna. In addition to that, Bionoid Pharma is 2.15 times more volatile than Avicanna. It trades about -0.1 of its total potential returns per unit of risk. Avicanna is currently generating about 0.05 per unit of volatility. If you would invest  20.00  in Avicanna on December 29, 2024 and sell it today you would earn a total of  1.00  from holding Avicanna or generate 5.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	96.83%
Values	Daily Returns

Bionoid Pharma  vs.  Avicanna

Bionoid Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bionoid Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Avicanna

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Avicanna are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Avicanna reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bionoid Pharma and Avicanna

The main advantage of trading using opposite Bionoid Pharma and Avicanna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Avicanna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avicanna will offset losses from the drop in Avicanna's long position.

The idea behind Bionoid Pharma and Avicanna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.